Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy
Saved in:
Main Author: | XU Jinghang |
---|---|
Format: | article |
Language: | ZH |
Published: |
Editorial Department of Journal of Clinical Hepatology
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b9bfc29d3a144849908c2dddbe0f738c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral therapy for chronic hepatitis B in the indeterminate phase is urgent
by: JIANG Jun
Published: (2021) -
Patients in the indeterminate phase of chronic hepatitis B virus infection should receive active antiviral therapy
by: WANG Jingyue
Published: (2021) -
Patients in the indeterminate phase of chronic hepatitis B virus infection should be treated
by: JIANG Yingying
Published: (2021) -
How far are we from the “Treat all” era of antiviral therapy for chronic hepatitis B
by: DING Yang
Published: (2021) -
Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
by: Lim TR
Published: (2014)